ctrl K

Frazier Lifesciences Acqu... (FLACU)

NASDAQ: FLACU · Real-Time Price · USD

9.50

0.23 (2.48%)

At close: Nov 22, 2022, 8:59 PM

Frazier Lifesciences Acquisition Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-2.29M	-1.99M	-344.62K	-454.57K	-369.23K	-305.24K	-237.24K	-127.66K
Interest Income	707.21K	102.85K	13.12K	2.92K	1.78K	7.02K	4.45K	n/a
Pretax Income	-4.78M	-1.17M	1.38M	929.7K	1.73M	-1.3M	2.82M	-126.81K
Net Income	-7.27M	-354.99K	3.13M	2.32M	1.73M	-1.3M	2.82M	-126.81K
Selling & General & Admin	2.26M	1.96M	344.62K	454.57K	369.23K	305.24K	237.24K	120.88K
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	120.88K
Operating Expenses	2.26M	1.96M	344.62K	454.57K	369.23K	305.24K	237.24K	120.88K
Interest Expense	2.49M	-817.9K	13.12K	2.92K	1.78K	7.02K	4.45K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.26M	1.96M	344.62K	454.57K	369.23K	305.24K	237.24K	120.88K
Income Tax Expense	2.49M	-817.9K	-1.74M	-1.39M	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	14.3M	14.3M	17.75M	17.75M	17.75M	3.95M	3.95M	3.11M
Shares Outstanding (Diluted)	14.3M	14.3M	17.75M	17.75M	17.75M	17.75M	13.8M	17.41M
EPS (Basic)	-0.51	-0.02	0.18	0.13	0.10	-0.33	0.71	-0.04
EPS (Diluted)	-0.51	-0.02	0.18	0.13	0.10	-0.07	0.20	-0.01
EBITDA	-4.78M	-1.17M	1.4M	932.62K	1.73M	-1.29M	2.82M	-126.81K
EBIT	n/a	n/a	1.4M	932.62K	1.73M	-1.29M	2.82M	n/a
Depreciation & Amortization	-2.49M	817.9K	1.74M	1.39M	2.1M	-987.03K	3.06M	851.00